Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences
Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma | CD20-positive Non-Hodgkin Lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-02-27 | NCT06021678 |